Topic
Biomarkers
18 Podcasts • 2 Courses on BackTable
Episode # 58 • 05 May 2026
Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options are available for second-line therapy? In this episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi explore the uncertain landscape of second-line treatment after first-line immunotherapy, such as atezolizumab and bevacizumab or the STRIDE regimen, including practical considerations for choosing which second-line therapy to use.
More on Biomarkers
Loading recent podcasts…
Tumor Board Episode #58
May 5, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
70+ listens
Tumor Board Episode #54
Apr 7, 2026
with Dr. Tyler Stewart, Dr. Jun Gong
Don’t miss the “curative window”! This episode takes a closer look at how evolving perioperative strategies and...
210+ listens
Urology Episode #275
Nov 21, 2025
with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam
When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern...
1,300+ listens
Urology Episode #269
Oct 28, 2025
with Dr. Jason Hafron, Dr. Ruchika Talwar
We have relied on PSA for decades, but what’s next in precision screening for prostate cancer? In this episode of...
1,700+ listens
Urology Episode #301
May 5, 2026
with Dr. Udit Singhal, Dr. Ruchika Talwar
Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across...
890+ listens
Curbsiders Episode #511
Jan 12, 2026
with Dr. Halima Amjad, Dr. Natalie Barrett, Dr. Matthew Watto, Dr. Paul Williams
From blood-based biomarkers to anti-amyloid treatments, join us as we explore the latest in Alzheimer's disease...
Urology Episode #271
Nov 7, 2025
with Dr. Katie Murray, Dr. Sarah Psutka, Dr. Vignesh Packiam
As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for...
1,300+ listens
Urology Episode #268
Oct 24, 2025
with Dr. Tyler Stewart, Dr. Bogdana Schmidt
With the introduction of checkpoint inhibitors into non-muscle invasive bladder cancer (NMIBC) management, who’s on...
1,100+ listens
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.